GlassScriptPhysician profile
Jennifer Vanmeter
NPI 1982978763
$1,780.43
in general payments reported to CMS, 2019-2025
17 companies · $289 in 2025
The $289 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $591 · 2023: $366 · 2024: $535 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,189.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $447.96 | 2022-2025 | |
| Agile Therapeutics, INC. | $203.64 | 2022-2024 | Twirla |
| Organon LLC | $186.64 | 2022-2025 | Nexplanon |
| Exeltis, USA INC. | $142.32 | 2022-2025 | Slynd |
| Coopersurgical, INC. | $127.39 | 2022-2024 | Paragard T 380a, Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $123.19 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $102.12 | 2022-2024 | Gardasil 9, Gardasil |
| Astellas Pharma US INC | $73.25 | 2023-2025 | Veozah |
| Biogen, INC. | $70.16 | 2025 | Zurzuvae |
| Shield Therapeutics INC | $62.47 | 2024 | |
| Myovant Sciences INC. | $52.05 | 2022 | |
| Mayne Pharma Commercial LLC | $39.00 | 2023 | |
| Exact Sciences Corporation | $38.57 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Vertex Pharmaceuticals Incorporated | $37.23 | 2025 | Journavx |
| Sumitomo Pharma America, INC. | $33.97 | 2023 | Myfembree |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $22.88 | 2022 | |
| Pfizer INC. | $17.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Vanmeter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.